Anti-Asthmatic Drugs Market Insights, Forecast to 2026

1. Report Title: Global and United States Anti-Asthmatic Drugs Market Insights, Forecast to 2026 Published On: October 2020 Category: Life Sciences Pages: 143 Report Overview: Anti-Asthmatic Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Asthmatic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Anti-Asthmatic Drugs market is segmented into Long-term Control Medications Quick-relief Medications (Rescue Medications) Medications for Allergy-induced Asthma Segment by Application, the Anti-Asthmatic Drugs market is segmented into Hospital Pharmacy Retail Pharmacy Online Pharmacy Regional and Country-level Analysis The Anti-Asthmatic Drugs market is analysed and market size information is provided by regions (countries). The key regions covered in the Anti-Asthmatic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. 24marketreports | International +1 646 781 7170 | www.24marketreports.com

2. Competitive Landscape and Anti-Asthmatic Drugs Market Share Analysis Anti-Asthmatic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Asthmatic Drugs business, the date to enter into the Anti-Asthmatic Drugs market, Anti-Asthmatic Drugs product introduction, recent developments, etc. The major vendors covered: Abdi Ibrahim Ception Therapeutics Elan Innoviva Novartis Sanofi Mitsubishi Tanabe Pharma Menarini Dong-A Socio Holdings Lonza Sosei Regeneron Pharmaceuticals Theravance Biopharma Lonza Table of Contents: 1 Study Coverage 1.1 Anti-Asthmatic Drugs Product Introduction 1.2 Market Segments 1.3 Key Anti-Asthmatic Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Anti-Asthmatic Drugs Market Size Growth Rate by Type 1.4.2 Long-term Control Medications 1.4.3 Quick-relief Medications (Rescue Medications) 1.4.4 Medications for Allergy-induced Asthma 1.5 Market by Application 1.5.1 Global Anti-Asthmatic Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Online Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Anti-Asthmatic Drugs Market Size, Estimates and Forecasts 24marketreports | International +1 646 781 7170 | www.24marketreports.com

3. 2.1.1 Global Anti-Asthmatic Drugs Revenue 2015-2026 2.1.2 Global Anti-Asthmatic Drugs Sales 2015-2026 2.2 Global Anti-Asthmatic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Anti-Asthmatic Drugs Historical Market Size by Region (2015-2020) 2.3.1 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Anti-Asthmatic Drugs Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Anti-Asthmatic Drugs Sales Forecast by Region (2021-2026) 2.4.2 Global Anti-Asthmatic Drugs Revenue Forecast by Region (2021-2026) 3 Global Anti-Asthmatic Drugs Competitor Landscape by Players 3.1 Global Top Anti-Asthmatic Drugs Sales by Manufacturers 3.1.1 Global Anti-Asthmatic Drugs Sales by Manufacturers (2015-2020) 3.1.2 Global Anti-Asthmatic Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Global Anti-Asthmatic Drugs Manufacturers by Revenue 3.2.1 Global Anti-Asthmatic Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Global Anti-Asthmatic Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Anti-Asthmatic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Anti-Asthmatic Drugs Revenue in 2019 3.2.5 Global Anti-Asthmatic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Anti-Asthmatic Drugs Price by Manufacturers 3.4 Global Anti-Asthmatic Drugs Manufacturing Base Distribution, Product Types 3.4.1 Anti-Asthmatic Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Anti-Asthmatic Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Anti-Asthmatic Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Anti-Asthmatic Drugs Market Size by Type (2015-2020) 4.1.1 Global Anti-Asthmatic Drugs Sales by Type (2015-2020) 4.1.2 Global Anti-Asthmatic Drugs Revenue by Type (2015-2020) 4.1.3 Anti-Asthmatic Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Anti-Asthmatic Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Anti-Asthmatic Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Anti-Asthmatic Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Anti-Asthmatic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Anti-Asthmatic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High- End 5 Market Size by Application (2015-2026) 5.1 Global Anti-Asthmatic Drugs Market Size by Application (2015-2020) 5.1.1 Global Anti-Asthmatic Drugs Sales by Application (2015-2020) 5.1.2 Global Anti-Asthmatic Drugs Revenue by Application (2015-2020) 5.1.3 Anti-Asthmatic Drugs Price by Application (2015-2020) 5.2 Anti-Asthmatic Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Anti-Asthmatic Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Anti-Asthmatic Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Anti-Asthmatic Drugs Price Forecast by Application (2021-2026) 24marketreports | International +1 646 781 7170 | www.24marketreports.com

4. 6 United States by Players, Type and Application 6.1 United States Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026 6.1.1 United States Anti-Asthmatic Drugs Sales YoY Growth 2015-2026 6.1.2 United States Anti-Asthmatic Drugs Revenue YoY Growth 2015-2026 6.1.3 United States Anti-Asthmatic Drugs Market Share in Global Market 2015-2026 6.2 United States Anti-Asthmatic Drugs Market Size by Players (International and Local Players) 6.2.1 United States Top Anti-Asthmatic Drugs Players by Sales (2015-2020) 6.2.2 United States Top Anti-Asthmatic Drugs Players by Revenue (2015-2020) 6.3 United States Anti-Asthmatic Drugs Historic Market Review by Type (2015-2020) 6.3.1 United States Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020) 6.3.2 United States Anti-Asthmatic Drugs Revenue Market Share by Type (2015-2020) 6.3.3 United States Anti-Asthmatic Drugs Price by Type (2015-2020) 6.4 United States Anti-Asthmatic Drugs Market Estimates and Forecasts by Type (2021-2026) 6.4.1 United States Anti-Asthmatic Drugs Sales Forecast by Type (2021-2026) 6.4.2 United States Anti-Asthmatic Drugs Revenue Forecast by Type (2021-2026) 6.4.3 United States Anti-Asthmatic Drugs Price Forecast by Type (2021-2026) 6.5 United States Anti-Asthmatic Drugs Historic Market Review by Application (2015-2020) 6.5.1 United States Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020) 6.5.2 United States Anti-Asthmatic Drugs Revenue Market Share by Application (2015-2020) 6.5.3 United States Anti-Asthmatic Drugs Price by Application (2015-2020) 6.6 United States Anti-Asthmatic Drugs Market Estimates and Forecasts by Application (2021-2026) 6.6.1 United States Anti-Asthmatic Drugs Sales Forecast by Application (2021-2026) 6.6.2 United States Anti-Asthmatic Drugs Revenue Forecast by Application (2021-2026) 6.6.3 United States Anti-Asthmatic Drugs Price Forecast by Application (2021-2026) 7 North America 7.1 North America Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026 7.2 North America Anti-Asthmatic Drugs Market Facts & Figures by Country 7.2.1 North America Anti-Asthmatic Drugs Sales by Country (2015-2020) 7.2.2 North America Anti-Asthmatic Drugs Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026 8.2 Europe Anti-Asthmatic Drugs Market Facts & Figures by Country 8.2.1 Europe Anti-Asthmatic Drugs Sales by Country 8.2.2 Europe Anti-Asthmatic Drugs Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026 9.2 Asia Pacific Anti-Asthmatic Drugs Market Facts & Figures by Country 9.2.1 Asia Pacific Anti-Asthmatic Drugs Sales by Region (2015-2020) 24marketreports | International +1 646 781 7170 | www.24marketreports.com

5. 9.2.2 Asia Pacific Anti-Asthmatic Drugs Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026 10.2 Latin America Anti-Asthmatic Drugs Market Facts & Figures by Country 10.2.1 Latin America Anti-Asthmatic Drugs Sales by Country 10.2.2 Latin America Anti-Asthmatic Drugs Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Anti-Asthmatic Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Anti-Asthmatic Drugs Sales by Country 11.2.2 Middle East and Africa Anti-Asthmatic Drugs Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Abdi Ibrahim 12.1.1 Abdi Ibrahim Corporation Information 12.1.2 Abdi Ibrahim Description and Business Overview 12.1.3 Abdi Ibrahim Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Abdi Ibrahim Anti-Asthmatic Drugs Products Offered 12.1.5 Abdi Ibrahim Recent Development 12.2 Ception Therapeutics 12.2.1 Ception Therapeutics Corporation Information 12.2.2 Ception Therapeutics Description and Business Overview 12.2.3 Ception Therapeutics Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Ception Therapeutics Anti-Asthmatic Drugs Products Offered 12.2.5 Ception Therapeutics Recent Development 12.3 Elan 12.3.1 Elan Corporation Information 12.3.2 Elan Description and Business Overview 12.3.3 Elan Sales, Revenue and Gross Margin (2015-2020) 24marketreports | International +1 646 781 7170 | www.24marketreports.com

6. 12.3.4 Elan Anti-Asthmatic Drugs Products Offered 12.3.5 Elan Recent Development 12.4 Innoviva 12.4.1 Innoviva Corporation Information 12.4.2 Innoviva Description and Business Overview 12.4.3 Innoviva Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Innoviva Anti-Asthmatic Drugs Products Offered 12.4.5 Innoviva Recent Development 12.5 Novartis 12.5.1 Novartis Corporation Information 12.5.2 Novartis Description and Business Overview 12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Novartis Anti-Asthmatic Drugs Products Offered 12.5.5 Novartis Recent Development 12.6 Sanofi 12.6.1 Sanofi Corporation Information 12.6.2 Sanofi Description and Business Overview 12.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Sanofi Anti-Asthmatic Drugs Products Offered 12.6.5 Sanofi Recent Development 12.7 Mitsubishi Tanabe Pharma 12.7.1 Mitsubishi Tanabe Pharma Corporation Information 12.7.2 Mitsubishi Tanabe Pharma Description and Business Overview 12.7.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Products Offered 12.7.5 Mitsubishi Tanabe Pharma Recent Development 12.8 Menarini 12.8.1 Menarini Corporation Information 12.8.2 Menarini Description and Business Overview 12.8.3 Menarini Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Menarini Anti-Asthmatic Drugs Products Offered 12.8.5 Menarini Recent Development 12.9 Dong-A Socio Holdings 12.9.1 Dong-A Socio Holdings Corporation Information 12.9.2 Dong-A Socio Holdings Description and Business Overview 12.9.3 Dong-A Socio Holdings Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Dong-A Socio Holdings Anti-Asthmatic Drugs Products Offered 12.9.5 Dong-A Socio Holdings Recent Development 12.10 Lonza 12.10.1 Lonza Corporation Information 12.10.2 Lonza Description and Business Overview 12.10.3 Lonza Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Lonza Anti-Asthmatic Drugs Products Offered 12.10.5 Lonza Recent Development 12.11 Abdi Ibrahim 12.11.1 Abdi Ibrahim Corporation Information 12.11.2 Abdi Ibrahim Description and Business Overview 12.11.3 Abdi Ibrahim Sales, Revenue and Gross Margin (2015-2020) 24marketreports | International +1 646 781 7170 | www.24marketreports.com

7. 12.11.4 Abdi Ibrahim Anti-Asthmatic Drugs Products Offered 12.11.5 Abdi Ibrahim Recent Development 12.12 Regeneron Pharmaceuticals 12.12.1 Regeneron Pharmaceuticals Corporation Information 12.12.2 Regeneron Pharmaceuticals Description and Business Overview 12.12.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Regeneron Pharmaceuticals Products Offered 12.12.5 Regeneron Pharmaceuticals Recent Development 12.13 Theravance Biopharma 12.13.1 Theravance Biopharma Corporation Information 12.13.2 Theravance Biopharma Description and Business Overview 12.13.3 Theravance Biopharma Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Theravance Biopharma Products Offered 12.13.5 Theravance Biopharma Recent Development 12.14 Lonza 12.14.1 Lonza Corporation Information 12.14.2 Lonza Description and Business Overview 12.14.3 Lonza Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Lonza Products Offered 12.14.5 Lonza Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter?s Five Forces Analysis 13.5 Primary Interviews with Key Anti-Asthmatic Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Anti-Asthmatic Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer Get More Information about the Report: 24marketreports | International +1 646 781 7170 | www.24marketreports.com

8. Report URL: https://www.24marketreports.com/life-sciences/global-united-states-antiasthmatic-drugs-2026-301 To get Report Sample: https://www.24marketreports.com/request-sample/global-united-states-antiasthmatic-drugs-2026-301 24marketreports | International +1 646 781 7170 | www.24marketreports.com